These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32312618)

  • 1. Why the four non-vitamin K-antagonist oral anticoagulants are actually five.
    Rubboli A
    Eur J Intern Med; 2020 Aug; 78():152-153. PubMed ID: 32312618
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of non-vitamin K antagonist oral anticoagulants in very elderly patients with atrial fibrillation: a single-center experience.
    Weronska A; Broniatowska E; Papuga-Szela E; Undas A
    Kardiol Pol; 2020 Feb; 78(2):154-157. PubMed ID: 32108756
    [No Abstract]   [Full Text] [Related]  

  • 3. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation.
    Kotalczyk A; Potpara TS; Lip GYH
    Expert Opin Pharmacother; 2021 Oct; 22(14):1807-1810. PubMed ID: 34148469
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.
    Song HY; Son KB; Shin JY; Bae S
    Int J Clin Pharm; 2019 Dec; 41(6):1434-1441. PubMed ID: 31522377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.
    Turagam MK; Velagapudi P; Flaker GC
    Clin Interv Aging; 2015; 10():1431-44. PubMed ID: 26366064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists.
    Gieling E; de Vries F; Williams R; van Onzenoort HAW; de Boer A; Ten Cate V; Kramers C; Burden A
    Int J Clin Pharm; 2019 Dec; 41(6):1536-1544. PubMed ID: 31595448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.
    Massaro A; Giugliano RP; Norrving B; Oto A; Veltkamp R
    Int J Stroke; 2016 Dec; 11(9):950-967. PubMed ID: 27703066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Hijazi Z; Wallentin L
    Circulation; 2016 Jul; 134(1):48-51. PubMed ID: 27358436
    [No Abstract]   [Full Text] [Related]  

  • 13. Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
    Briere JB; Bowrin K; Millier A; Toumi M; Wojciechowski P; Taieb V
    J Med Econ; 2019 Aug; 22(8):760-765. PubMed ID: 30969801
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin K antagonists for RHD-associated AF.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2022 Nov; 19(11):721. PubMed ID: 36114418
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced dose and reduced exposure to non-vitamin K-antagonist oral anticoagulants: Some considerations on this relationship.
    Rubboli A; Verheugt FWA
    Int J Cardiol; 2016 Nov; 223():519-520. PubMed ID: 27552569
    [No Abstract]   [Full Text] [Related]  

  • 16. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.
    Hsu JC; Freeman JV
    Clin Pharmacol Ther; 2018 Aug; 104(2):301-310. PubMed ID: 29328506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the non-vitamin K oral anticoagulants for atrial fibrillation.
    P Giugliano R
    Ther Adv Cardiovasc Dis; 2017 Mar; 11(3):77-79. PubMed ID: 28190378
    [No Abstract]   [Full Text] [Related]  

  • 18. Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review.
    Russo V; Bottino R; Rago A; Micco PD; D' Onofrio A; Liccardo B; Golino P; Nigro G
    Semin Thromb Hemost; 2019 Mar; 45(2):205-214. PubMed ID: 30119139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
    Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM
    Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.